Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) Cash from Operations Growth (3y) (2012 - 2026)

Analysis

Quest Diagnostics (DGX) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 39.21%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 10.37%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 8.23%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 14.98%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 31.29%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 35.23%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 136.17%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.37%
Mar 31, 2026 43.54%
Dec 31, 2025 11.66%
Sep 30, 2025 3.90%
Jun 30, 2025 10.61%
Mar 31, 2025 -13.19%
Dec 31, 2024 -1.19%
Sep 30, 2024 -14.07%
Jun 30, 2024 -7.85%
Mar 31, 2024 -40.50%
Dec 31, 2023 -0.87%
Sep 30, 2023 -37.84%
Jun 30, 2023 7.74%
Mar 31, 2023 -27.53%
Dec 31, 2022 -1.36%
Sep 30, 2022 18.85%
Jun 30, 2022 7.79%
Mar 31, 2022 20.40%
Dec 31, 2021 17.70%
Sep 30, 2021 11.75%